KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $2.5 million.

  • Biogen's Exchange Rate Effect rose 10336.02% to $2.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $101.9 million, marking a year-over-year increase of 25051.7%. This contributed to the annual value of $101.9 million for FY2025, which is 25051.7% up from last year.
  • According to the latest figures from Q4 2025, Biogen's Exchange Rate Effect is $2.5 million, which was up 10336.02% from -$3.2 million recorded in Q3 2025.
  • Biogen's Exchange Rate Effect's 5-year high stood at $68.3 million during Q2 2025, with a 5-year trough of -$74.4 million in Q4 2024.
  • For the 5-year period, Biogen's Exchange Rate Effect averaged around -$2.3 million, with its median value being -$6.8 million (2022).
  • In the last 5 years, Biogen's Exchange Rate Effect plummeted by 52500.0% in 2022 and then skyrocketed by 64206.35% in 2025.
  • Quarter analysis of 5 years shows Biogen's Exchange Rate Effect stood at -$15.8 million in 2021, then skyrocketed by 525.32% to $67.2 million in 2022, then dropped by 28.72% to $47.9 million in 2023, then crashed by 255.32% to -$74.4 million in 2024, then soared by 103.36% to $2.5 million in 2025.
  • Its last three reported values are $2.5 million in Q4 2025, -$3.2 million for Q3 2025, and $68.3 million during Q2 2025.